Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;8(12):1030.
doi: 10.1016/S2215-0366(21)00396-5.

Antipsychotics and COVID-19: the debate goes on

Xavier Boland  1 , Luiz Dratcu  2
Affiliations
Comment

Antipsychotics and COVID-19: the debate goes on

Xavier Boland et al. Lancet Psychiatry. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment in

Comment on

References

    1. Vai B, Mazza MG, Delli Colli C, et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8:797–812. - PMC - PubMed
    1. Howard R, Burns A, Schneider L. Antipsychotic prescribing to people with dementia during COVID-19. Lancet Neurol. 2020;19:892. - PMC - PubMed
    1. Taipale H, Mittendorfer-Rutz E, Alexanderson K, et al. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res. 2018;197:274–280. - PubMed
    1. Dratcu L, Boland X. Can antipsychotic use protect from COVID-19? Schizophr Res. 2021;236:1–2. - PMC - PubMed
    1. Canal-Rivero M, Catalán-Barragán R, Rubio-García A, et al. Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: a retrospective epidemiological study in a representative Spanish population. Schizophr Res. 2021;229:53–54. - PMC - PubMed

Substances